1. Home
  2. AEHR vs CGEM Comparison

AEHR vs CGEM Comparison

Compare AEHR & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aehr Test Systems

AEHR

Aehr Test Systems

HOLD

Current Price

$35.58

Market Cap

858.8M

Sector

Industrials

ML Signal

HOLD

Logo Cullinan Oncology Inc.

CGEM

Cullinan Oncology Inc.

HOLD

Current Price

$15.68

Market Cap

780.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AEHR
CGEM
Founded
1977
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.8M
780.4M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
AEHR
CGEM
Price
$35.58
$15.68
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$21.00
$29.89
AVG Volume (30 Days)
1.6M
764.5K
Earning Date
04-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$58,968,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$60.20
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.27
$5.68
52 Week High
$46.95
$16.74

Technical Indicators

Market Signals
Indicator
AEHR
CGEM
Relative Strength Index (RSI) 52.61 66.47
Support Level $20.22 $6.65
Resistance Level N/A $16.74
Average True Range (ATR) 4.34 1.07
MACD 0.20 0.16
Stochastic Oscillator 46.06 78.91

Price Performance

Historical Comparison
AEHR
CGEM

About AEHR Aehr Test Systems

Aehr Test Systems is engaged in test systems for burning-in and testing logic, optical, and memory integrated circuits. Increased quality and reliability needs of the Automotive and Mobility integrated circuit markets. The Company operates in one business segment, the designing, manufacturing, marketing and selling of advanced test and burn-in products to the semiconductor manufacturing industry in several geographic areas. The company provides production solutions across the product manufacturing flow to improve yield and reliability and has developed and introduced several inventive products, including the ABTSTM and FOX-PTM families of test and burn-in systems and FOX WaferPakTM Aligner, FOX-XP WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.

Share on Social Networks: